Brief: IRLAB Q4 Sales SEK 14.7 Million
25/02/2026 06:00
Feb 25 (Reuters) - IRLAB Q4 EBIT SEK -21.9 million. Q4 operating cash flow SEK -26 million Q4 adjusted EPS SEK -0.29
IRLAB A — IRLAB Therapeutics AB News Story
0.000.00%
Last trade - 00:00- SEK168.35m
- SEK158.33m
- SEK57.46m